Penguin Good News | Congratulations on the Partnership Between Weiming Penguin and Sainuo!
Article images may contain Chinese text.
Congratulations to Weiming Penguin on Signing with
Kunming Sainuo Pharmaceutical Co., Ltd.
for a Data and Application Services Project

About Sainuo Pharmaceutical
Kunming Sainuo Pharmaceutical Co., Ltd. was established in 1998 with registered capital of RMB 70 million. It has been recognized as a Yunnan Province High-Tech Enterprise and a Yunnan Enterprise with Intellectual Property Advantages. In 2011, the provincial government named it one of 50 major enterprises selected for priority development in the biopharmaceutical industry during the 12th Five-Year Plan. In 2012, it became one of Kunming's first pilot enterprises for technological innovation. That same year, "Sainuo" was recognized as a Well-Known Trademark of Kunming, and in 2013 it was recognized as a Famous Trademark of Yunnan Province. Its product areas include antiviral treatments for hepatitis B, cardiovascular and cerebrovascular treatments, gastrointestinal and trauma treatments, and topical medicines for orthopedic injuries. Sainuo Pharmaceutical has always regarded new drug research and development as the lifeline of its long-term strategic development. It focuses on R&D and sustained investment, continuously improving and growing stronger.
About Weiming Penguin
Weiming Penguin's data management system offers security, stability, timeliness, accuracy, a lightweight design, and strong compatibility. It supports a range of functions, including automatic monitoring, automatic recollection, and automatic upgrades. Extensive databases and AI-powered data cleansing solutions deliver a cleansing efficiency of over 95%, with human assistance providing additional support. Weiming Penguin's extensive data services experience, industry-leading technical capabilities, and proven, mature products have earned widespread praise.
